- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
LabCorp's earnings call took place on the heels of a media report earlier this month that the company was in discussions to buy Pharmaceutical Product Development.
The contract research organization has been viewed as a logical takeout target of LabCorp. for some time now.